Form 4: Novanta CEO Sells 323 Shares Under 10b5-1 Plan
Insider Transaction Report
Novanta Inc.'s CEO, Matthijs Glastra, sold 323 shares of common stock for $130.14 per share on January 8, 2026, as part of a pre-established 10b5-1 trading plan.
Summary
- Matthijs Glastra, Chief Executive Officer and Director of Novanta Inc. (NOVT), sold 323 shares of common stock.
- The transaction occurred on January 8, 2026, at a weighted-average price of $130.14 per share.
- This sale was executed pursuant to a pre-established Rule 10b5-1 trading plan adopted on September 11, 2025.
- The 10b5-1 plan was set up through a trust for which Mr. Glastra's spouse is a trustee.
- Following the transaction, Mr. Glastra directly owns 85,044 shares and indirectly owns 54,382 shares through the Matthijs Glastra 2021 Irrevocable Trust.
Sentiment
Score: 5
Explanation: A neutral score as the sale was pre-scheduled under a 10b5-1 plan, which typically mitigates concerns about insider confidence, though it is still a sale by a key executive.
Negatives
- An insider sale, even if pre-scheduled, can sometimes be perceived as a minor negative signal regarding management's confidence, though this is a small amount relative to total holdings.
Risks
- Potential for negative investor sentiment if the sale is misinterpreted as a lack of confidence, despite being pre-scheduled under a 10b5-1 plan.
Future Outlook
NA
Management Comments
- The sales reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan that was adopted on September 11, 2025 through a trust for which the reporting person's spouse is a trustee.
- This transaction was executed in multiple trades ranging from $130.06 to $130.23. The price reported above reflects the weighted-average price.
Industry Context
This filing reports a routine insider transaction and does not provide information related to broader industry trends or competitive landscape.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Insider Trading Policy Adherence | The transaction was conducted under a Rule 10b5-1 trading plan, demonstrating adherence to insider trading regulations designed to prevent trading on material non-public information. | 2025-09-11 | Enhances transparency and reduces the risk of insider trading allegations for the reporting person. |
Related Party Transactions
- The sale was executed through a trust for which the reporting person's spouse is a trustee, indicating a related party involvement in the transaction mechanism.
Stakeholder Impact
- Shareholders: Minor impact due to a relatively small, pre-scheduled sale by a key executive, which is a routine disclosure.
Key Dates
| Date | Description |
|---|---|
| 2025-09-11 | Date the Rule 10b5-1 trading plan was adopted. |
| 2026-01-08 | Date of the common stock transaction (sale). |
| 2026-01-12 | Date the Form 4 was signed by the attorney-in-fact. |
Recommendation
holdThe Form 4 reports a pre-scheduled sale by the CEO under a 10b5-1 plan, which is a routine disclosure and does not typically signal a change in the company's fundamental outlook or warrant a change in investment recommendation based solely on this filing. The amount sold is also relatively small compared to the executive's total holdings.
Keywords
Novanta Inc., NOVT, Matthijs Glastra, insider trading, Form 4, stock sale, 10b5-1 plan, CEO, director, equity transaction
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.